BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31196496)

  • 41. OncoSurge: a strategy for long-term survival in metastatic colorectal cancer.
    Alberts S; Poston G
    Colorectal Dis; 2003 Nov; 5 Suppl 3():20-8. PubMed ID: 23573557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Augmented Reality Guidance for the Resection of Missing Colorectal Liver Metastases: An Initial Experience.
    Ntourakis D; Memeo R; Soler L; Marescaux J; Mutter D; Pessaux P
    World J Surg; 2016 Feb; 40(2):419-26. PubMed ID: 26316112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.
    Morris-Stiff G; White AD; Gomez D; Cameron IC; Farid S; Toogood GJ; Lodge JP; Prasad KR
    Eur J Surg Oncol; 2014 Aug; 40(8):1016-20. PubMed ID: 24370284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.
    Yan TD; Padang R; Morris DL
    J Am Coll Surg; 2006 Jan; 202(1):100-11. PubMed ID: 16377503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survival and Prognostic Factors of Colorectal Liver Metastases After Surgical and Nonsurgical Treatment.
    Lemke J; Cammerer G; Ganser J; Scheele J; Xu P; Sander S; Henne-Bruns D; Kornmann M
    Clin Colorectal Cancer; 2016 Dec; 15(4):e183-e192. PubMed ID: 27269232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review.
    Goey KK; 't Lam-Boer J; de Wilt JH; Punt CJ; van Oijen MG; Koopman M
    Eur J Cancer; 2016 Dec; 69():166-177. PubMed ID: 27821320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exploring the Outcome of Disappearance or Small Remnants of Colorectal Liver Metastases during First-Line Chemotherapy on Hepatobiliary Contrast-Enhanced and Diffusion-Weighted MR Imaging.
    Boraschi P; Moretto R; Donati F; Borelli B; Mercogliano G; Giugliano L; Boccaccino A; Della Pina MC; Colombatto P; Signori S; Masi G; Cremolini C; Urbani L
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
    Leung U; Gönen M; Allen PJ; Kingham TP; DeMatteo RP; Jarnagin WR; D'Angelica MI
    Ann Surg; 2017 Jan; 265(1):158-165. PubMed ID: 28009741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of disappearing colorectal hepatic metastases.
    Carpenter S; Fong Y
    Adv Surg; 2010; 44():269-79. PubMed ID: 20919526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
    Pak LM; Kemeny NE; Capanu M; Chou JF; Boucher T; Cercek A; Balachandran VP; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; D'Angelica MI
    J Surg Oncol; 2018 Mar; 117(4):634-643. PubMed ID: 29165816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colorectal liver metastases: disappearing lesions in the era of Eovist hepatobiliary magnetic resonance imaging.
    Owen JW; Fowler KJ; Doyle MB; Saad NE; Linehan DC; Chapman WC
    HPB (Oxford); 2016 Mar; 18(3):296-303. PubMed ID: 27017170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laparoscopic versus open liver resection for colorectal liver metastases: A systematic review and meta-analysis of studies with propensity score-based analysis.
    Zhang XL; Liu RF; Zhang D; Zhang YS; Wang T
    Int J Surg; 2017 Aug; 44():191-203. PubMed ID: 28583897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases.
    Khoo E; O'Neill S; Brown E; Wigmore SJ; Harrison EM
    HPB (Oxford); 2016 Jun; 18(6):485-93. PubMed ID: 27317952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of postoperative oxaliplatin- or irinotecan-based chemotherapy after curative resection of synchronous liver metastases from colorectal cancer.
    Hsu HC; Chou WC; Shen WC; Wu CE; Chen JS; Liau CT; Lin YC; Yang TS
    Anticancer Res; 2013 Aug; 33(8):3317-25. PubMed ID: 23898098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of disappearing colorectal liver metastases.
    Kuhlmann K; van Hilst J; Fisher S; Poston G
    Eur J Surg Oncol; 2016 Dec; 42(12):1798-1805. PubMed ID: 27260846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synchronous colorectal liver metastases: the "surgeon as oncologist" perspective.
    Shah K; Clary B
    Minerva Chir; 2013 Feb; 68(1):49-76. PubMed ID: 23584266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of complete pathologic response and hepatic injuries between hepatic arterial infusion and systemic administration of oxaliplatin in patients with colorectal liver metastases.
    Allard MA; Sebagh M; Baillie G; Lemoine A; Dartigues P; Faitot F; Faron M; Boige V; Vitadello F; Vibert E; Elias D; Adam R; Goéré D; Sa Cunha A
    Ann Surg Oncol; 2015; 22(6):1925-32. PubMed ID: 25448804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.
    Meijerink MR; Puijk RS; van Tilborg AAJM; Henningsen KH; Fernandez LG; Neyt M; Heymans J; Frankema JS; de Jong KP; Richel DJ; Prevoo W; Vlayen J
    Cardiovasc Intervent Radiol; 2018 Aug; 41(8):1189-1204. PubMed ID: 29666906
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease.
    Hwang M; Jayakrishnan TT; Green DE; George B; Thomas JP; Groeschl RT; Erickson B; Pappas SG; Gamblin TC; Turaga KK
    Eur J Cancer; 2014 Jul; 50(10):1747-1757. PubMed ID: 24767470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. "Liver-first" approach for synchronous colorectal liver metastases: is this a justifiable approach?
    De Rosa A; Gomez D; Brooks A; Cameron IC
    J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):263-70. PubMed ID: 23325126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.